Psoralea corylifolia L. (Babchi): A Comprehensive Review of Its Phytochemistry, Pharmacology and Ethnomedicinal Applications in the AYUSH (Unani) System of Medicine
Abstract
Psoralea corylifolia L., commonly known as Babchi, is a well-known medicinal plant that has been utilized for centuries in traditional medical systems such as Ayurveda, Siddha, and particularly the Unani system of medicine, where it is referred to as Babchi. Belonging to the Fabaceae family, P. corylifolia is native to tropical and subtropical regions, including China, South Africa, and extensively across the Indian subcontinent—namely Maharashtra, West Bengal, Uttar Pradesh, Rajasthan, Karnataka, Bihar, and the Deccan plateau.
In the Unani system, different parts of the plant are used therapeutically: roots for dental caries; leaves for diarrhoea; fruits for conditions such as anaemia, asthma, bronchitis, dysuria, inflammation, and vomiting; and seeds for skin conditions like scabies, ulcers, vitiligo, leucoderma, eczema, leprosy, and psoriasis. Phytochemical investigations have revealed more than seventy bioactive compounds, including flavonoids, coumarins, Quinone’s, phenols, benzofurans, benzopyrans, sesquiterpenoids, triterpenes, and steroids. Various pharmacological activities have been reported, such as anti-inflammatory, hepatoprotective, hemostatic, antioxidant, antimicrobial, antibacterial, antifungal, anti-obesity, antiviral, anti-mutagenic, anti-filarial, estrogenic, anticancer, anti-asthmatic, anti-diabetic, anti-aging, and immunomodulatory properties. Additionally, potential therapeutic effects have been observed in Alzheimer’s disease and alopecia areata.
Several traditional and proprietary Unani formulations such as Roghan Babchi, Sufoof-e-Babchi, Zimad-e-Bars, Habb-e-Bars, and Habb-e-Hindi are commercially available for therapeutic use. This review aims to consolidate classical Ethnomedicinal knowledge and recent pharmacological research on P. corylifolia to facilitate its broader integration into evidence-based phytomedicine.
Keywords. Psoralea corylifolia, Babchi, Dermatological disorders, Unani medicine.
Keywords:
Psoraliya corylifoliya, Babchi, vitiligo, unani medicineDOI
https://doi.org/10.22270/jddt.v15i8.7318References
1. Ansari S, Khan QA, Anjum R, Siddiqui A, Sultana K, European Journal of Biomedical and Pharmaceutical …, 2017 Fundamentals of Unani system of medicine-a review. http://www.ejbps.com/
2. Parveen A, Parveen R, Akhatar A, Parveen B, Siddiqui KM, Iqbal M. Concepts and quality considerations in Unani system of medicine. Journal of AOAC International. 2020;103(3):609-33. https://doi.org/10.5740/jaoacint.19-0284 PMid:31547901
3. Ahmad B, Akhtar J. Unani system of medicine. Pharmacogn Rev. 2007;1(2):210-14. http://www.phcogrev.com/
4. Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. Springer; 2007.
5. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants Used in Ayurveda. Vol. 4. CCRAS; 2001.
6. Singh G, Kumar S, Sharma P, Sharma AK. Phytochemical and pharmacological profile of Psoralea corylifolia L.: A review. J Appl Pharm Sci. 2017;7(10):239–245.
7. Patel D, Kumar R, Prasad SK, Hemalatha S. Psoralea corylifolia L.: An overview. J Ethnopharmacol. 2016;207:56–66.
8. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol. 1997;133(12):1525–1528.
9. Misra N, Chandra D. Psoralea corylifolia seeds: A review. Int J Ayurveda Res. 2011;2(2):71–79.
10. The Ayurvedic Pharmacopoeia of India. Part I, Vol. I. Govt. of India, Ministry of Health & Family Welfare, Department of AYUSH; 1999.
11. Ghani HN. Khazain-ul- Advia. Idara Kitab-us-Shifa, Edn. 2005;1:316-317.
12. The Unani Pharmacopeia of India Part-1,Vol-1. Delhi: Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. of India India; 2007. 11–12, 88–89 p
13. Tariq NA. Taj al-Mufradat. Idara Kitab-us-Shifa, 2075, Kucha Chelan, Darya Ganj; 2010. 39–41, 100,101, 638–39, 622–24, 535–36 p.
14. Abdul Hakeem HM. Bustanul Mufradat Jadeed. New Delhi.: Idara Kitab al Shifa; 2002. 109, 509–10, 598, 428–29p
15. Kabīruddin HM. Makhzan al-Mufridāt al-Mārūf khawas al-Advia. Delhi: CCRUM, Ministry of Health and Family Welfare, Govt. of India; 2007. 441, 442, 504, 505 p
16. Khan MA. Muhit-I-Azam, Urdu Translation. Vol. I, Central Council for Research in Unani Medicine, Ministry of Health and Family Welfare, New Delhi India. 2012. 213-510,512,513p.
17. Chopra B, Dhingra AK, Dhar KL. Psoralea corylifolia L. (Buguchi)—Folklore to modern Review. Fitoterapia. 2013;90:44-56. Evidence
18. Anonymous. The Wealth of India, Publications & Information Directorate (PID), CSIR, New Delhi, 1995; 8:296-298.
19. Nadkarni KM. Indian Materia Medica, Popular Prakashan, Pvt. Ltd. Mumbai, Edn 3rd. 1999;1:1019 1021.
20. Rafeequddin M, Kanz-ul-Advia Mufrada. First Edition, published by university publication unit, Sarfaraz House, AMU, Aligarh, 1985, 131-132.
21. Rastogi RP, Mehra BN. Compendium of Indian medicinal plants, Central Drug Research institute, Lucknow, publications and information directorate, New Delhi,1991; 1:322
22. Abdul Hakeem HM. Bustanul Mufradat Jadeed. New Delhi.: Idara Kitab al Shifa; 2002. 109, 509–10, 598, 428–29p
23. Khan MS, Lari QH, et al. Babchi (Psoralea corylifolia Linn.) and it’s therapeutic uses in Unani system of medicine, International Journal of Pharmaceutical and Phytopharmacological Research. 2015;5(1):41-45.
24. Kirtikar KR, Basu BD. Indian medicinal plant, International Book Distributors, Edn, 2nd. 1975;4:2581- 2583.
25. Rafeequddin M, Kanz-ul-Advia Mufrada. First Edition, published by university publication unit, Sarfaraz House, AMU, Aligarh, 1985, 131-132
26. Hakīm K. Al-Qarābādīn. Tabaʻ Sāni. New Delhi: Central Council For Research in Unani Medicine; 2006. 222p.
27. Khan Shareef Hk. Ilaj-ul-amraz 2nd edition (Urdu translation by CCRUM). New Delhi: Ministry of Health and Family Welfare: published 2005 p 816
28. Najmul Ghani Khan. (2010). Qarabadeen Najmul Ghani. New Delhi: Central Council for Research in Unani Medicine (CCRUM), Ministry of AYUSH, Government of India.
29. Mukherjee PK. Business Horizons Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals, New Delhi, 2002, 761-3.
30. Maisch JM. Useful plants of the genus Psoralea. The American Journal of Pharmacy. 1889;61(7).
31. Kokate C.K., Purohit A.P., Gokhale S.B., Pharmacognosy, 49th Edition, Nirali Prakashan.
32. Trease and Evans Pharmacognosy, 16th Edition, Saunders Elsevier.
33. Wealth of India: A Dictionary of Indian Raw Materials and Industrial Products, Vol. VIII (Ph–Re), CSIR, New Delhi.
34. Sharma P, Yelne M, Dennis T, Joshi A, Billore K. Database on medicinal plants used in Ayurveda, 2000.
35. Chopra RN, et al. Indigenous Drug of India, Edition, UN Dhur, and Sons Pvt. Ltd., Calcutta. 1958;3rd:391 392
36. Alam F, Khan GN, Asad Bin. Psoralea corylifolia L: Ethnobotanical, biological, and chemical aspects: A review [Internet]. Vol. 32, Phytotherapy Research. 2018. p. 597–615. Available from: https://www.researchgate.net/publication/321855975
37. Kim KA, Shim SH, Ahn HR, Jung SH. Protective effects of the compounds isolated from the seed of Psoralea corylifolia on oxidative stress‐induced retinal damage. Toxicology and Applied Pharmacology. 2013;269(2):109-120. https://doi.org/10.1016/j.taap.2013.03.017
38. Buyukbalci A, Sedef Nehir EI. Determination of in vitro antidiabetic effects, antioxidant activities and phenol contents of some herbal teas, Plants Food Hum Nutr. 2008;63(1):27- 33. https://doi.org/10.1007/s11130-007-0065-5
39. Forestieri AM, Monfortre MT, Ragusa S, Trovato A, Lauk L. Anti-inflammatory, Analgesic and antipyretic activity in rodents of plant extract used in African medicine phytother Res. 1996; 10(2):100-103. https://doi.org/10.1002/(SICI)1099-1573(199603)10:2%3C100::AID-PTR724%3E3.0.CO;2-I
40. Chen CH, Hwang TL, Chen LC, Tsung-Hsien Chang TH, Wei CH, Chen JJ. Isoflavones and antiinflammatory constituents from the fruits of Psoralea corylifolia, Phytochemistry, 2017; 143:186-193. https://doi.org/10.1016/j.phytochem.2017.08.004
41. Kim DW, Seo KH, Curtis‐Long MJ, Oh KY, Oh JW, Cho JK, et al. Phenolic phytochemical displaying SARS‐CoV papain‐like protease inhibition from the seeds of Psoralea corylifolia. Journal of Enzyme Inhibition and Medicinal Chemistry. 2014;29(1):59-63. https://doi.org/10.3109/14756366.2012.753591
42. Aslan M, Orhan N, Orhan DD, Ergun F. Hypoglycemic activity and antioxidant potential of some medicinal plants traditionally used in Turkey for diabetes, J Ethnopharmacol. 2010;128(2):384-389. https://doi.org/10.1016/j.jep.2010.01.040
43. Iwamura J, Dohi T, Tanaka H, Odani T, Kubo M. Cytotoxicity of Corylifolia fructus. II. Cytotoxicity of bakuchiol and the analogues. Yakugaku zasshi: Journal of the Pharmaceutical 1989;109(12):962-965. Society of Japan. https://doi.org/10.1248/yakushi1947.109.12_962
44. Gidwani, beena, alaspure, RN, duragkar, NJ, singh, vijay, RAO, S.prakash, & shukla, S.S.. (2010). Evaluation of a novel herbal formulation in the treatment of eczema with psoralea corylifolia. Iranian journal of dermatology, 13(4 (54)), 122-127. Sid. https://sid.ir/paper/579609/en
45. Wang, Y.; Hong, C.; Zhou, C.; Xu, D.; Qu, H.B. Screening anti-tumour compounds psoralen and isopsoralen from Psoralea corylifolia L. Seeds. Evidence-Based Compl. Alt. Med., 2011, 363052. https://doi.org/10.1093/ecam/nen087
46. Chen, Z.; Jin, K.; Gao, L.; Lou, G.; Jin, Y.; Yu, Y.; Lou, Y. Anti-tumor effects of bakuchiol, an analogue of resveratrol, on human lung adenocarcinoma A549 cell line. Eur. J. Pharmacol., 2010, 643(2-3), 170-179. https://doi.org/10.1016/j.ejphar.2010.06.025
47. Yang, Y.; Paik, J. H.; Cho, D.; Cho, J.A.; Kim, C.W. Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells. Int. Immunopharmacol., 2008, 8(4), 542-547. https://doi.org/10.1016/j.intimp.2007.12.006
48. Wang TX, Yin ZH, Zhang W, Peng T, Kang WY. Chemical constituents from Psoralea corylifolia and their antioxidant alpha‐glucosidase inhibitory and antimicrobial activities, Zhongguo Zhong Yao Za Zhi. 2013a;38(14):2328-2333. https://europepmc.org/search?query=JOURNAL%3A%22Zhongguo%20Zhong%20Yao%20Za%20Zhi%22
49. Hosamani P, Lakshman H, Sandeepkumar K. Antimicrobial activity of leaf extract of Psoralea corylifolia L. Life Science Leaflets, 2012. http://lifesciencesleaflets.ning.com/
50. Limper C, Wang Y, Ruhl S, Wang Z, Lou Y, Totzke F, et al. Compounds isolated from Psoralea corylifolia seeds inhibit protein kinase activity and induce apoptotic cell death in mammalian cells. Journal of Pharmacy and Pharmacology. 2013;65(9):1393-1408. https://doi.org/10.1111/jphp.12107
51. Cho H, Jun JY, Song EK, Kang KH, Baek HY, Ko YS, Kim YC. “Bakuchiol: A hepatoprotective compound of Psoralea corylifolia on tacrine – induced cytotoxicity in Hep G2 cells” Planta Med. 2001; 67(08):750-751. https://doi.org/10.1055/s-2001-18347
52. Ghosh D, Bera T, Chatterjee K, Ali K, Debasis D. Antidiabetic and antioxidative effects of aqueous extract of seed of Psoralea corylifolia (somraji) and seed of Trigonella foenum‐graecum L., (methi) in separate and composite manner in streptozotocin‐induced diabetic male albino rat. Intl J Pharm Res Dev. 2009;7(9):1-10.
53. Ling F, Lu C, Tu X, Yi Y, Huang A, Zhang Q, et al. Antiprotozoal screening of traditional medicinal plants: Evaluation of crude extract of Psoralea corylifolia against Ichthyophthirius multifiliis in goldfish, Parasitology Research. 2013;112(6):2331-2340. https://doi.org/10.1007/s00436-013-3397-0
54. Latha PG, Evans DA, Panikkar KR. Jayavardhanan KK. Immunomodulatory and antitumour properties of Psoralea corylifolia seeds. Fitoterapia. 2000;71(3):223 231. https://doi.org/10.1016/S0367-326X(99)00151-3
55. Khare CP. Indian Medicinal Plants An Illustrated Dictionary. 1st ed. New York: Springer Science + Business Media; 2007. 5–6, 75–76, 266–67, 523, 733–34 p.
Published
Abstract Display: 627 
PDF Downloads: 483 PDF Downloads: 124 How to Cite
Issue
Section
Copyright (c) 2025 Abdullah, Yasmeen Khan , Labeeb Shaida, Abdul Kabeer, Mohd. Noman Taha
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.